Ligand validation:3IAG

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3IAG_EDO_C_1	59%	73%	0.152	0.933	0.33	0.71	-	-	6	0	100%	1
3IAG_EDO_C_3	29%	72%	0.265	0.927	0.33	0.75	-	-	4	0	100%	1
3IAG_EDO_C_6	26%	88%	0.222	0.865	0.6	0.09	-	-	0	0	100%	1
3IAG_EDO_A_16	18%	56%	0.193	0.775	0.94	0.77	-	-	0	0	100%	1
3IAG_EDO_C_2	14%	67%	0.288	0.841	0.37	0.87	-	-	0	0	100%	1
3IAG_EDO_C_4	4%	75%	0.417	0.803	0.42	0.56	-	-	1	0	100%	1
7RTE_EDO_C_502	10%	83%	0.33	0.839	0.5	0.29	-	-	1	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.44	0.35	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.